Recursion Pharmaceuticals, Inc. RXRX Business Segments — Consumables

Similar metrics at other companies

ROLReportable Segment — Materials and supplies

$53.22M+9.7%

ARD

ARDTReportable Segment — Supplies

$268.55M+3.7%

GRALReportable Segment — Laboratory supplies and research collaborations

$1.42M-61.3%

NXTReportable Segment — Material cost

$525.06M-9.9%

CLDXSingle Reportable — Supplies Expense

$1.46M-32.7%

YETIReportable Segment — Cost of goods sold

$170.2M+13.9%

Questions, answered.

What is Recursion Pharmaceuticals, Inc.'s business segments — consumables?

Recursion Pharmaceuticals, Inc. (RXRX) reported business segments — consumables of $7.15M in Q1 2026.

How has Recursion Pharmaceuticals, Inc.'s business segments — consumables changed year-over-year?

Recursion Pharmaceuticals, Inc.'s business segments — consumables decreased by 86.9% year-over-year, from $54.68M to $7.15M.

What is the long-term trend for Recursion Pharmaceuticals, Inc.'s business segments — consumables?

Over 3 years (2022 to 2025), Recursion Pharmaceuticals, Inc.'s business segments — consumables has grown at a 43.1% compound annual growth rate (CAGR), from $35.11M to $102.91M.

What does business segments — consumables mean?

Refers to the costs associated with materials and supplies that are consumed during the normal course of research, development, or manufacturing operations. High or increasing levels of this expense often correlate with the scaling of laboratory activities or production volume.